A stake by France-owned Bpifrance and promise of local job retention have allayed political backlash over the sale of ...

PARIS (Reuters) -French drugmaker Sanofi said on Monday it had entered exclusive talks to sell a 50% controlling stake in its ...

Sanofi is now in “exclusive negotiations” with U.S. private equity firm Clayton, Dubilier & Rice (CD&R) to sell a 50% ...

Sanofi said on Monday it had entered exclusive talks for the sale of a 50% controlling stake in its consumer health business ...

Sanofi and CD&R announce today a plan to join forces to fuel Opella’s ambitions as a French-headquartered, global consumer ...

Sanofi SNY has entered into exclusive negotiations with U.S.-based private equity company Clayton Dubilier & Rice (CD&R) for ...

Sanofi and CD&R partner to fuel Opella’s ambitions in consumer healthcareSanofi and CD&R enter exclusive negotiations to transfer a 50% ...

French pharma major Sanofi has opened negotiations to sell a 50% controlling stake in its consumer health business Opella to ...

在制药行业的一项重大举措中，纳斯达克上市公司赛诺菲（NASDAQ:SNY）已与美国私募股权公司Clayton Dubilier & Rice（CD&R）就出售其消费者健康业务Opella的50%控股权益展开独家谈判。

French pharmaceutical company Sanofi has entered exclusive talks to sell a 50% stake in its consumer health business Opella ...

French drama over sovereign paracetamol is really about a deeper ailment: underinvestment.

智通财经获悉，赛诺菲(SNY.US)周一表示，已就将其消费者保健业务Opella 50%的控股权出售给美国私募股权公司Clayton Dubilier & ...